Table 3.

Chemical Analyte Descriptive Statistics in Snart Foraeldre/Milieu Population and NHANES Population.^a^,^b

	Snart Foraeldre/Milieu					NHANES^c

	N	GM	10th Pctl	95th Pctl	% >LOD	N^c	GM	10th Pctl	95th Pctl	% >LOD	NHANES Year
Cotinine (ng/mL)
Cotinine	73	0.09	0.01	120	86	1216	36.58	0.011	258	100	11–12
Metals_Blood (ng/mL except lead which is μg/dL)
Blood cadmium	73	0.2	0.071	0.76	88	1234	0.46	0.11	1.57	84.12	11–12
Blood manganese	73	10.52	7.66	17.65	100	1234	10.95	6.84	18.69	100	11–12
Blood lead	73	0.81	0.53	1.58	100	1234	0.72	0.32	1.54	97.57	11–12
Blood selenium	73	115.02	98.52	140	100	1234	192.0	162.88	234.96	100	11–12
Blood mercury, total	73	1.59	0.69	5.2	97	1234	1.14	0.21	3.79	96.84	11–12
Metals (ng/mL)
Barium	50	0.68	0.17	2.7	100	410	1.57	0.29	4.34	98.54	11–12
Cadmium	50	0.1	0.03	0.52	80	410	0.19	0.04	0.63	80.73	11–12
Cobalt	50	0.28	0.07	1.06	100	410	0.55	0.10	1.58	98.78	11–12
Cesium	50	2.97	0.95	10.6	100	410	4.39	1.13	10.8	100	11–12
Molybdenum	50	25.98	5.54	134	100	410	47.01	9.04	121	100	11–12
Lead	50	0.24	0.08	0.88	98	410	0.35	0.06	1.58	91.22	11–12
Antimony	50	0.04	0.02	0.15	72	410	0.06	0.03	0.15	54.39	11–12
Tin	46	0.16	0.06	0.63	65	410	1.00	0.16	4.04	79.02	11–12
Strontium	50	79.69	22.06	333.39	100	410	107.94	20.04	282.98	100	11–12
Thallium	50	0.15	0.04	0.46	100	410	0.18	0.05	0.44	99.27	11–12
Tungsten	50	0.05	0.01	0.28	78	409	0.18	0.02	0.44	80.44	11–12
Uranium	50	0	0	0.02	68	410	0.01	0.002	0.02	64.88	11–12
Arsenic, total	57	9.25	1.9	48.34	100	410	14.77	1.83	54.90	94.15	11–12
Arsenic Metabolites (ng/mL)
Arsenobetaine	57	5.51	0.82	53.8	78	412	8.49	0.84	36.90	49.03	11–12
Dimethylarsonic acid	57	2.93	1.35	7.46	69	412	4.53	1.27	11.40	76.7	11–12
Monomethylarsonic acid	57	0.43	0.14	1.64	69	412	0.79	0.63	1.51	24.03	11–12
PAH Biomarkers (ng/L)
1-hydroxynaphthalene	56	309.32	72.81	5907.16	98	410	3806.53	248	19,250	100	11–12
1-hydroxyphenanthrene	56	67.92	23.26	589.83	98	410	178.78	36	540	99.76	11–12
1-hydroxypyrene	56	58.96	20.00	458.60	98	410	212.64	34	671	99.27	11–12
2-hydroxyfluorene	56	95.32	24.68	865.00	100	410	512.62	49	2394	100	11–12
2-hydroxynaphthalene	56	1158.68	237.54	15,869.08	100	410	9464.10	854	30,078	100	11–12
2-hydroxyphenanthrene	56	30.94	7.07	230.47	88	410	86.93	17	246	96.83	11–12
3-hydroxyfluorene	56	39.49	10.61	499.19	91	409	244.84	16	1257	97.07	11–12
3-hydroxyphenanthrene	56	30.68	7.07	278.56	84	410	91.71	15	295	94.39	11–12
4-hydroxyphenanthrene	56	13.73	7.07	99.37	46	409	30.17	7.1	96	75.79	11–12
9-hydroxyfluorene	56	113.1	28.81	1178.22	100	410	409.88	47	1216	100	11–12
Brominated Flame Retardants (pg/g)
PBDE153	73	6.43	3.6	14.2	95	363	66.47	8.6	319.1	92.56	03–04
PCBs (ng/g)
PCB99	73	0.02	0.01	0.04	99	326	0.02	0.01	0.06	100	03–04
PCB138 & 158	73	0.11	0.05	0.28	100	332	0.07	0.02	0.18	100	03–04
PCB146	73	0.02	0.01	0.06	99	331	0.01	0	0.02	98.49	03–04
PCB153	73	0.16	0.07	0.39	100	331	0.08	0.02	0.22	100	03–04
PCB170	73	0.04	0.02	0.12	99	332	0.02	0.01	0.05	97.69	03–04
PCB178	73	0.01	0	0.03	82	331	0	0	0.01	71.3	03–04
PCB180	73	0.10	0.04	0.28	100	332	0.06	0.01	0.16	100	03–04
PCB183	73	0.01	0.01	0.03	96	332	0.01	0	0.02	87.95	03–04
PCB187	72	0.03	0.01	0.09	100	332	0.02	0	0.04	98.8	03–04
PCB194	73	0.01	0.01	0.04	25	322	0.01	0	0.04	78.26	03–04
PCB199	73	0.01	0.00	0.04	86	330	0.01	0	0.03	85.76	03–04
Persistent Pesticides (ng/g)
Hexachlorobenzene	73	0.06	0.04	0.1	100	36	0.05	0.04	0.07	100	07–08
p,p′-DDE	73	0.18	0.09	0.62	99	36	1.14	0.41	2.63	100	07–08
Perchlorate (ng/mL)
Perchlorate	56	2.14	0.53	18.9	100	401	3.56	0.75	11.1	100	11–12
Phenols (ng/mL)
Butyl Paraben	56	0.29	0.53	1.58	63	409	3.31	0.14	16.2	46.21	11–12
benzophenone-3	56	3.64	0.14	211	86	409	462.61	10.4	2230	99.76	11–12
bisphenol A	56	0.99	0.2	6.7	95	409	2.91	0.28	10.60	88.51	11–12
Methyl Paraben	56	18.16	2.2	475	96	409	264.89	7.30	1120.0	100	11–12
Propyl Paraben	56	1.67	0.07	228	86	409	80.65	1.20	309.0	99.27	11–12
Phthalates (ng/mL)
Mono-n-butyl phthalate	56	5.41	1.1	37.2	95	409	19.37	0.5	46.8	91.69	11–12
Mono-benzyl phthalate	56	1.37	0.21	10.2	82	409	10.11	0.50	37.3	97.56	11–12
Mono(carboxynonyl) phthalate	56	0.37	0.14	1.8	66	409	3.83	0.7	11.4	98.53	11–12
Mono(carboxyoctyl) phthalate	56	2.3	0.5	20.2	96	409	59.67	4	248.9	100	11–12
Mono-(3-carboxypropyl) phthalate	56	0.47	0.14	2.6	63	409	9.31	0.5	30.0	97.8	11–12
Mono–2-ethyl–5-carboxypentyl phthalate	56	4.72	1.1	31.6	98	409	25.08	3.1	76.8	99.76	11–12
Mono–2-ethyl–5-hydroxyhexyl phthalate	56	2.83	0.8	14.7	96	409	15.99	1.1	49.5	99.76	11–12
Mono–2-ethylhexyl phthalate	56	0.75	0.35	4.1	95	409	3.87	0.35	9.7	75.06	11–12
Mono–2-ethyl–5-oxohexyl phthalate	56	1.91	0.4	11.5	95	409	10.58	1.2	31.9	99.27	11–12
Monoethyl phthalate	56	12.53	2.1	163	98	409	138.24	12.5	388.0	99.76	11–12
Mono-isobutyl phthalate	56	11.72	1.8	138	100	409	11.71	1.2	35.1	98.53	11–12
Phytoestrogens (ng/mL)
Daidzein	56	34.75	2.6	791	98	497	462.34	6.5	1980	100	09–10
O-Desmethylangolensin	56	0.99	0.14	35.3	88	497	121.86	0.3	597	94.16	09–10
Equol	56	15.87	3.01	194	100	497	115.99	2.84	81.3	100	09–10
Enterodiol	56	82.11	8.2	1440	100	497	157.17	5.17	553	99.4	09–10
Enterolactone	56	836.79	141	8360	100	497	669.63	16.3	2610	100	09–10
Genistein	56	6.96	0.5	245	98	497	217.07	3.2	545	100	09–10
Diakylphosphate Metabolites (ng/mL)
Diethylphosphate	55	0.55	0.07	5.67	75	425	3.53	3.53	14.7	31.06	07–08
Dimethylthiophosphate	56	0.5	0.07	4.97	77	426	7.26	7.26	36.8	73.94	07–08
Organophosphates (ng/mL)
3,5,6-trichloropyridinol	56	0.66	0.07	5.59	88	482	1.34	0.07	4.02	80.71	09–10
Para-nitrophenol	55	0.32	0.07	2.86	78	482	0.79	0.07	2.65	78.01	09–10
PFAS (ng/mL)
Perfluorodecanoic acid	73	0.27	0.2	0.5	100	375	0.24	0.07	0.64	80	11–12
Perfluorohexane sulfonic acid	73	0.31	0.2	0.7	100	375	1.21	0.33	4.28	97.87	11–12
Perfluorononanoic acid	73	0.58	0.3	1.1	100	375	0.93	0.37	2.07	99.73	11–12
Perfluorooctanoic acid	73	1.55	0.7	3.9	100	375	1.88	0.75	3.15	100	11–12
Perfluorooctane sulfonic acid	73	5.55	2.6	11.7	100	375	5.36	1.76	12.50	0	11–12

Biomarkers chosen for inclusion and if detected in over 60% of the population.

Results presented in volumetric concentrations.

The number of NHANES women included in analysis varied because of missing data, whether the biomarker was measured in a pooled subsample of the NHANES population and by sampling year. As a result, between 36 and 1234 women were included to obtain the NHANES concentrations for each biomarker. In the Danish study population, the number of women included in descriptive statistics analyses varied due to missing data.